Form 4 for GNLX GENELUX Corp
Accepted 2023-09-12 00:00:00 ET · period of report 2023-09-11 · accession 0001209191-23-049096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-12 | 2023-09-11 | GNLX | Smalling Ralph | Head of Regulatory | A - Grant | $0.00 | +10.0K | 12.1K | +484% | $0 |
| D | 2023-09-12 | 2023-09-11 | GNLX | Smalling Ralph | Head of Regulatory | A - Grant | $0.00 | +54.0K | 54.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-11 | A | A | 10,000 | $0.00 | 12,065 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2023-09-11 | A | A | 54,000 | $0.00 | 54,000 | D | $22.40 · — to 2033-09-10 | 54,000 Common Stock | (F2) 25% of the shares shall vest on September 11, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter. |